Coeptis Therapeutics, Inc. Long-Term Debt, Maturity, Year Three
Coeptis Therapeutics, Inc. had Long-Term Debt, Maturity, Year Three of $0 as of 2022-06-30, per its 10-Q filed 2022-08-02.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree · last filed 2022-11-08
- 2022-06-30: Long-Term Debt, Maturity, Year Three $0.00.
- 2022-03-31: Long-Term Debt, Maturity, Year Three $0.00.
- 2021-12-31: Long-Term Debt, Maturity, Year Three $0.00.
- 2021-09-30: Long-Term Debt, Maturity, Year Three $5.28K.
| Period end | Long-Term Debt, Maturity, Year Three |
|---|---|
| 2022-06-30 | $0.00 10-Q · filed 2022-08-02 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-08 |
| 2021-09-30 | $5.28K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $5.28K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $5.28K 10-Q/A · filed 2021-05-18 |